See more : Oncodesign Société Anonyme (ALONC.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Kitanotatsujin Corporation (2930.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kitanotatsujin Corporation, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Aston Minerals Limited (ASO.AX) Income Statement Analysis – Financial Results
- Realfiction Holding AB (publ) (REALFI.ST) Income Statement Analysis – Financial Results
- ReGen Biologics Inc. (RGBOQ) Income Statement Analysis – Financial Results
- Kiora Pharmaceuticals, Inc. (KPRX) Income Statement Analysis – Financial Results
- Kenmec Mechanical Engineering Co., Ltd. (6125.TWO) Income Statement Analysis – Financial Results
Kitanotatsujin Corporation (2930.T)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.kitanotatsujin.com
About Kitanotatsujin Corporation
Kitanotatsujin Corporation plans, develops, manufactures, and sells health foods, cosmetics, and miscellaneous goods in Japan. It offers health foods and beauty products under the J North Farm brand. The company also sell its products through its e-commerce website. Kitanotatsujin Corporation was founded in 2000 and is headquartered in Sapporo, Japan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 14.67B | 9.83B | 9.51B | 9.27B | 10.09B | 8.30B | 5.29B | 2.70B | 2.22B | 1.94B | 1.78B |
Cost of Revenue | 3.83B | 2.53B | 2.34B | 2.25B | 2.45B | 1.85B | 1.06B | 620.87M | 609.18M | 524.63M | 491.31M |
Gross Profit | 10.83B | 7.30B | 7.17B | 7.02B | 7.65B | 6.45B | 4.23B | 2.08B | 1.61B | 1.42B | 1.29B |
Gross Profit Ratio | 73.86% | 74.29% | 75.37% | 75.74% | 75.74% | 77.69% | 79.97% | 76.98% | 72.59% | 72.97% | 72.44% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 4.14B | 3.19B | 2.81B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 5.18B | 3.56B | 2.23B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 9.31B | 6.74B | 5.04B | 4.84B | 4.66B | 4.53B | 2.75B | 1.52B | 1.21B | 0.00 | 0.00 |
Other Expenses | 72.00M | 27.21M | 96.36M | 12.49M | 6.51M | 2.16M | 1.50M | 2.99M | -4.54M | -6.17M | 1.37M |
Operating Expenses | 9.38B | 6.79B | 5.09B | 4.99B | 4.73B | 4.59B | 2.82B | 1.53B | 1.22B | 956.33M | 903.45M |
Cost & Expenses | 13.22B | 9.32B | 7.43B | 7.24B | 7.18B | 6.44B | 3.88B | 2.15B | 1.82B | 1.48B | 1.39B |
Interest Income | 126.00K | 121.00K | 74.00K | 83.00K | 24.00K | 26.00K | 18.00K | 129.00K | 237.00K | 160.00K | 25.00K |
Interest Expense | 1.28M | 1.97M | 2.45M | 0.00 | 47.00K | 348.00K | 672.00K | 477.00K | 215.00K | 778.00K | 1.49M |
Depreciation & Amortization | 138.76M | 128.75M | 89.85M | 21.44M | 23.74M | 13.02M | 12.34M | 12.49M | 9.38M | 4.74M | 2.33M |
EBITDA | 1.64B | 661.41M | 2.16B | 2.07B | 2.94B | 1.86B | 1.42B | 551.46M | 356.54M | 449.28M | 389.92M |
EBITDA Ratio | 11.17% | 6.83% | 23.94% | 22.19% | 29.20% | 22.59% | 26.82% | 20.77% | 18.12% | 23.45% | 21.96% |
Operating Income | 1.45B | 510.15M | 2.08B | 2.03B | 2.92B | 1.86B | 1.40B | 542.05M | 397.76M | 459.70M | 387.63M |
Operating Income Ratio | 9.88% | 5.19% | 21.89% | 21.91% | 28.88% | 22.42% | 26.56% | 20.10% | 17.90% | 23.69% | 21.75% |
Total Other Income/Expenses | 49.57M | 20.55M | -11.06M | 13.08M | 3.87M | -12.39M | -1.42M | -3.56M | -50.81M | -15.94M | -1.53M |
Income Before Tax | 1.50B | 530.69M | 2.07B | 2.04B | 2.92B | 1.85B | 1.40B | 538.50M | 346.95M | 443.76M | 386.10M |
Income Before Tax Ratio | 10.22% | 5.40% | 21.78% | 22.05% | 28.92% | 22.27% | 26.53% | 19.97% | 15.61% | 22.87% | 21.66% |
Income Tax Expense | 504.06M | 187.02M | 731.82M | 656.33M | 944.38M | 556.13M | 454.09M | 181.77M | 120.17M | 174.99M | 149.98M |
Net Income | 994.66M | 343.67M | 1.34B | 1.39B | 1.97B | 1.29B | 948.37M | 356.73M | 226.78M | 268.77M | 236.12M |
Net Income Ratio | 6.78% | 3.50% | 14.11% | 14.97% | 19.56% | 15.57% | 17.94% | 13.23% | 10.20% | 13.85% | 13.25% |
EPS | 7.15 | 2.47 | 9.66 | 9.99 | 14.21 | 9.30 | 6.81 | 2.70 | 1.71 | 2.13 | 1.92 |
EPS Diluted | 7.15 | 2.47 | 9.66 | 9.99 | 14.21 | 9.28 | 6.81 | 2.60 | 1.64 | 2.04 | 1.92 |
Weighted Avg Shares Out | 139.11M | 139.03M | 138.98M | 138.97M | 138.97M | 139.05M | 139.26M | 132.22M | 132.61M | 126.26M | 122.91M |
Weighted Avg Shares Out (Dil) | 139.11M | 139.03M | 138.98M | 138.97M | 138.97M | 139.36M | 139.26M | 137.20M | 138.42M | 131.70M | 122.91M |
Source: https://incomestatements.info
Category: Stock Reports